SuperSonic raises cash to accelerate Aixplorer sales
SuperSonic Imagine has raised EUR 28 million with EUR 14 million invested by the French Investment Fund alongside two new investors, Alto Invest and Kuwait Life Sciences Company (KLSC) and a substantial subscription from the company's previous investors. Edmond de Rothschild Investment Partners, Auriga Partners, Omnes Capital (formerly Crédit Agricole Private Equity), CDC Entreprises, NBGI Ventures, Wellington Partners, iXO Private Equity and Mérieux Développement, along with Alto Invest and KLSC, are subscribing to EUR 14 million.
SuperSonic Imagine will invest the funds to accelerate international sales and marketing of its Aixplorer ultrasound device, a product that covers all fields of general radiology and is certified in 54 countries. The new injection of funds will allow SuperSonic to take a leap forward in company's commercial development with a particular focus on the Chinese market.
In 2009, SuperSonic Imagine was granted 510(k) clearance by the FDA in the US and CE mark in Europe for the marketing of Aixplorer. Distribution agreements have been signed with Hologic for the breast market in the US and Canon for Japan.
As a result of the expansion of its addressable market, SuperSonic Imagine registered strong growth in 2012 with a turnover of EUR 14 million, up 40 per cent from the previous year, 80 per cent of which came from international sales.